Jeffrey Dierks, Chief Commercial Officer at Harmony Biosciences Holdings, Inc. (HRMY), sold 28,942 shares at $49.87 ($1.4M) on 2022-04-01, disclosed to the SEC on 2022-04-05.
Open-market sale of $1.4M HRMY by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.36 | 6,765 | $334K | 23.2% |
| 2 | $49.36 | 6,765 | $334K | 23.2% |
| 3 | $49.87 | 7,706 | $384K | 26.8% |
| 4 | $49.87 | 7,706 | $384K | 26.8% |
| Total | $49.63 avg | 28,942 | $1.4M | 100% |
| Filing → |
| HRMY | SELL | 2025-01-21 | $2.3M | — | Filing → |
| HRMY | SELL | 2025-01-16 | $778K | — | Filing → |
| HRMY | SELL | 2025-01-15 | $532K | — | Filing → |